⌘K
Loading ticker…
As of 2026-08-24, ANI Pharmaceuticals, Inc. (ANIP) has a 3-month relative strength percentile of 30 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 45. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 3.2%, relative volume 0.88×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY diluted average shares. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
ANIP appears in 1 ETF as of Jun 2026: PSC at 0.16% weight, $4M notional.
Held by 93 ETFs · $378M across latest filings · largest weight 3.04% (PJP).
Top 1 by value, from SEC N-PORT-P filings dated Jun 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| PSC | 0.16% | $4M | −0.02 pp |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ANIP Jan avg: 5.55% median: 4.88% win: 100% σ: 4.25% n: 4 2022-04-12 → 2026-07-31 | ANIP Feb avg: 2.65% median: -0.46% win: 50% σ: 14.02% n: 4 2022-04-12 → 2026-07-31 | ANIP Mar avg: 2.33% median: 3.11% win: 75% σ: 5.54% n: 4 2022-04-12 → 2026-07-31 | ANIP Apr avg: -0.15% median: -0.30% win: 40% σ: 4.75% n: 5 2022-04-12 → 2026-07-31 | ANIP May avg: 0.45% median: -1.18% win: 40% σ: 13.12% n: 5 2022-04-12 → 2026-07-31 | ANIP Jun avg: 6.40% median: 5.44% win: 60% σ: 9.03% n: 5 2022-04-12 → 2026-07-31 | ANIP Jul avg: 1.81% median: -2.38% win: 40% σ: 8.13% n: 5 2022-04-12 → 2026-07-31 | ANIP Aug avg: 18.71% median: 15.12% win: 75% σ: 21.92% n: 4 2022-04-12 → 2026-07-31 (current) | ANIP Sep avg: -7.79% median: -8.12% win: 0% σ: 4.66% n: 4 2022-04-12 → 2026-07-31 | ANIP Oct avg: 5.32% median: 2.62% win: 50% σ: 10.76% n: 4 2022-04-12 → 2026-07-31 | ANIP Nov avg: -4.25% median: -3.19% win: 25% σ: 11.79% n: 4 2022-04-12 → 2026-07-31 | ANIP Dec avg: -0.94% median: -3.75% win: 25% σ: 7.91% n: 4 2022-04-12 → 2026-07-31 |